NULL

Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Kore

Malaysia

Philippines

Coxevac box and bottle
Coxevac box and bottle

Coxevac

Coxevac is an inactivated phase 1 vaccine designed to protect against Q Fever.

 

Used in cattle to lower the risk of non-infected animals becoming shedders of Coxiella burnetii, and to reduce overall shedding on infected farms via milk, faeces and vaginal mucus.

 

In goats and sheep, to reduce abortion caused by Coxiella burnetii and to reduce shedding of the bacterium via milk, vaginal mucus, faeces and placenta.

Available in:

  • 40 ml

Target species:

  • cattle icon Cattle
  • Goat
  • sheep icon Sheep

Product information

How to use

Dose: cattle 4mls, sheep & goats 2mls

  • Suspension for subcutaneous injection, in the neck region
    Can be administered from 3 months of age
  • Two doses should be given with an interval of 3 weeks as primary course and followed by a periodic booster
  • Withdrawal: Cattle milk – zero hours, meat – zero days. Small ruminants: meat, milk and offal – zero days.

Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet at www.noahcomendium.co.uk or on request.

Legal Category: POMV

SPC

Why choose
Coxevac?

Fewer abortions

Vaccinated cows are 30% less likely to abort when compared to unvaccinated herds1

Less shedding

Lowers the probability of an animal becoming a shedder by 5 times and reduces the shedding of C. burnetii2 decreasing the impact of the disease in the herd

Empowers the Immunity

Coxevac vaccine induces optimal cellular and humoral immune responses

Reduces environmental load

Whole herd vaccination reduces the bacterial load across the herd, reducing the environmental burden, so reducing the risk of other animals and humans being exposed to the pathogen3,4

References

1. Ordronneau, S., 2012. Impact de la vaccination et de l’antibiothérapie sur l’incidence des troubles de la reproduction et sur la fertilité dans des troupeaux bovins laitiers infectés par Coxiella burnet ...

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.